Clinical Trial Update: Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia [Phase 1]

View source ↗

Summary

Phase 1 multicenter trial evaluating 9-aminocamptothecin (9-AC) in patients with refractory leukemia, including acute myeloid leukemia and acute lymphoblastic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• 9-Aminocamptothecin (9-AC) (9-aminocamptothecin)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Leukemia, Myelocytic, Acute, Acute Lymphocytic Leukemia | Phase 1 | Status: COMPLETED